Skip to content
OpenCapital
Get started

Ashland ASH Life Sciences — Operating Income

Other segment segments

Personal Care And Household
$27M-3.6%
Unallocated And Other
-$20M-81.8%
Specialty Additives
-$7M-200%
Intermediates And Solvents
$4M+500%

Similar metrics at other companies

Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Operating Income (Loss)
$954M+14.4%
Danaher logo
DHRLife Sciences — Operating Income (Loss)
$225M+11.9%
STERIS logo
STELife Sciences: — Segment operating income
$61.8M+6.4%
STERIS logo
STELife Sciences: — Operating Income (Loss), Before Adjustments
$61.8M+6.4%
Revvity logo
RVTYLife Sciences — Segment operating income
$103.98M-1.6%
Donaldson Company logo
DCILife Sciences Segment — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
$6.8M+17.2%

Other financials

Income statement

See full
Revenue$482.0M+0.6%
Gross profit$147.0M0.0%
Operating income$39.0M-23.5%
Net income$16.0M-48.4%
EPS (diluted)$0.34-47.7%

Balance sheet

See full
Cash & equivalents$343.0M+104%
Total debt$1.5B-0.6%
Total equity$1.9B-27.1%
Total assets$4.5B-14.0%

Cash flow

See full
Operating cash flow$50.0M+456%
CapEx$17.0M-19.0%
Free cash flow$33.0M+375%

Valuation

See full
Market cap$2.93B-9.0%
Enterprise value$4.06B-10.6%
P/S1.6×0.0×

Profitability

See full
Gross margin30%-1.7pp
Operating margin-37.3%—
Net margin-40.8%-48.8pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity-33.4%-38.5pp
Debt / equity0.8×+0.2×
Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ashland's life sciences — operating income?
Ashland (ASH) reported life sciences — operating income of $35M in Q1 2026.
How has Ashland's life sciences — operating income changed year-over-year?
Ashland's life sciences — operating income increased by 25.0% year-over-year, from $28M to $35M.
What is the long-term trend for Ashland's life sciences — operating income?
Over 3 years (2021 to 2024), Ashland's life sciences — operating income has grown at a 8.9% compound annual growth rate (CAGR), from $130M to $168M.
What does life sciences — operating income mean?
This represents the profit or loss generated by the Life Sciences segment after deducting operating expenses such as cost of goods sold, research and development, and selling, general, and administrative costs. It serves as a primary indicator of the segment's core operational efficiency and business health. It excludes interest, taxes, and non-operating items to isolate business-level performance.